Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series.

Vazquez, Sara R; Wilson, Aaron S; Witt, Daniel M

Vazquez, Sara R; Wilson, Aaron S; Witt, Daniel M.

Vazquez SR; Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT, 84112, USA. sara.vazquez@hsc.utah.edu.
Wilson AS; University of Utah Health Thrombosis Clinic, 6056 South Fashion Square Drive, Suite 1200, Murray, UT, 84107, USA. sara.vazquez@hsc.utah.edu.
Witt DM; Department of Pharmacotherapy, University of Utah College of Pharmacy, 30 South 2000 East, Salt Lake City, UT, 84112, USA.

J Thromb Thrombolysis ; 54(4): 583-586, 2022 11.

Article in English | MEDLINE | ID: covidwho-2129007

Subject(s)

Anticoagulants; Ritonavir; Humans; Ritonavir/therapeutic use; Anticoagulants/therapeutic use; Drug Interactions

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ritonavir / Anticoagulants Limits: Humans Language: English Journal: J Thromb Thrombolysis Journal subject: Vascular Diseases Year: 2022 Document Type: Article Affiliation country: S11239-022-02707-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google